Mark H. Zangmeister Cancer Center

Recent papers from Mark H. Zangmeister Cancer Center

1. Results of a phase 2 study of a novel DLL4-VEGF, a bispecific antibody, tovecimig (CTX-009), as a monotherapy in patients with refractory metastatic colorectal cancer (COMPANION-003).Journal of Clinical Oncology · 2026
2. The impacts of Medicare biosimilar reimbursement policies.JCO Oncology Practice · 2025
3. Rethinking systemic anti-cancer therapy in the last 14 days of life in the era of oral oncology.JCO Oncology Practice · 2025
4. Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine Cancer.2025
5. Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal AdenocarcinomaJAMA Surgery · 2024
6. SWOG/NCI Phase II Dual Anti–CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian CancerClinical Cancer Research · 2024
7. Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignanciesGynecologic Oncology · 2024
8. Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention InitiativeJCO Precision Oncology · 2021
9. Phase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal CancerClinical Cancer Research · 2020
10. The combination of ibrutinib and rituximab demonstrates activity in first‐line follicular lymphomaBritish Journal of Haematology · 2020
11. Radiation Recall Dermatitis After Treatment of Stage IV Breast Cancer with Nivolumab: A Case ReportImmunotherapy · 2020
12. NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2+Journal of Clinical Oncology · 2019
13. A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patientsJAMIA Open · 2019
14. Multi-omic molecular comparison of primary versus metastatic pancreatic tumoursBritish Journal of Cancer · 2019
15. Biweekly cisplatin and gemcitabine in patients with advanced biliary tract cancerInternational Journal of Cancer · 2017
16. Gemcitabine and carfilzomib induced thrombotic microangiopathy: eculizumab as a life‐saving treatmentClinical Case Reports · 2017
17. Outcomes of definitive chemoradiation in patients with esophageal cancerDiseases of the Esophagus · 2016
18. Iatrogenic Lower Extremity Subcutaneous Emphysema after Prolonged Robotic-Assisted HysterectomyCase Reports in Obstetrics and Gynecology · 2015
19. Relapsing intracranial plasma cell granuloma: A case reportOncology Letters · 2013
20. Absence of pharmacokinetic drug–drug interaction of pertuzumab with trastuzumab and docetaxelAnti-Cancer Drugs · 2013